New study aims to cut risky pills for seniors with arthritis

NCT ID NCT07278609

Recruiting now Knowledge-focused Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a doctor's computer tool (MedSafer) and patient brochures (EMPOWER) can help reduce the use of potentially harmful medications in adults aged 60 and older with rheumatic diseases who take five or more regular drugs. Researchers will follow 100 participants for 18-20 months, comparing medication changes before and after introducing these tools. The goal is to improve medication safety without affecting quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MedSafer deprescribing reports and EMPOWER brochures
What this could lead to: If successful, this could provide a simple way to reduce unnecessary or risky medications in older adults with rheumatic conditions, improving safety without harming quality of life.
What could go wrong: This is a small, early-stage observational study, not a large trial. The results may not apply to all patients, and deprescribing might not always be safe or acceptable to doctors or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID ANTIBODY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acquired idiopathic inflammatory myopathy antiphospholipid syndrome arthritic joint disease autoimmune disease crystal arthropathy musculoskeletal system disorder osteoarthritis psoriatic arthritis rheumatic disorder rheumatoid arthritis Sjogren syndrome spondyloarthropathy systemic lupus erythematosus systemic sclerosis vasculitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATORY ARTHRITIS MUSKULOSKELETAL DISEASES RHEUMATIC DISEASES SYSTEMIC AUTOIMMUNE DISEASES SYSTEMIC LUPUS ERTHEMATOSUS (SLE) VASCULITIS

Contacts and locations

Locations

Montreal General Hospital, McGill University Health Centre
RECRUITING

Montreal, Quebec, H3G1A4, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.